AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 13:1062-1066, December 2005
© 2005 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uchida, N.
Right arrow Articles by Kuroda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uchida, N.
Right arrow Articles by Kuroda, S.

Regular Article

A Variant of the Sigma Receptor Type-1 Gene Is a Protective Factor for Alzheimer Disease

Naohiko Uchida, M.D., Hiroshi Ujike, M.D., Ph.D., Yuji Tanaka, M.D., Ph.D., Ayumu Sakai, M.D., Ph.D., Mitsutoshi Yamamoto, M.D., Ph.D., Yoshikatsu Fujisawa, M.D., Ph.D., Akihiro Kanzaki, M.D., Ph.D., and Shigetoshi Kuroda, M.D., Ph.D.

Received December 28, 2004; revised May 31, 2005; accepted June 4, 2005. From the Dept. of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (NU,HU,YT,AS,SK), Nishikawa Hospital, Hamada, Japan (NU), Kasaoka Hospital, Kasaoka, Japan (AS), the Dept. of Neurology, Kagawa Prefectural Central Hospital, Takamatsu, Japan (MY), Kinoko Espoir Hospital, Kasaoka, Japan (YF), and the Dept. of Neurology, Hiroshima City Hospital, Hiroshima, Japan (AK). Send correspondence and reprint requests to Hiroshi Ujike, M.D., Ph.D., Dept. of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho 2-5-1, Okayama 700-8558, Japan. e-mail: hujike{at}cc.okayama-u.ac.jp
© 2005 American Association for Geriatric Psychiatry

Objective: Some preclinical evidence suggests that the sigma receptor type 1, which plays several roles in learning and memory, may also be involved in the pathogenesis of Alzheimer disease (AD). The authors provide here genetic evidence that the sigma receptor type 1 (SIGMAR1) gene is involved in susceptibility to AD. Methods: Two polymorphisms of the SIGMAR1 gene, G-241T/C-240T and Q2P, were analyzed in a Japanese sample of 239 patients with AD and 227 comparisons subjects. These two polymorphisms were in complete linkage disequilibrium with each other, resulting in only two haplotypes, GC-241-240Q2 and TT-241-240P2. Results: There was a significant association between AD and the TT-241-240P2 haplotype of the SIGMAR1 gene and its homozygote, found with late-onset, but not early-onset AD. After stratification by {epsilon}4 allele status of the apolipoprotein E gene, TT-241-240P2 homozygosity of the SIGMAR1 gene reduced the risk of AD in {epsilon}4 allele carriers by three-fourths. Conclusion: The present study suggests that the TT-241-240P2 haplotype of the SIGMAR1 gene, which decreases expression of the gene, may have a protective role against susceptibility to AD.

Key Words: Alzheimer Disease • Genetics • Polymorphism • Protective Factors




This article has been cited by other articles:


Home page
AJGPHome page
D. J. Smith
Basic Brain Research Shows Its Age
Am J Geriatr Psychiatry, December 1, 2005; 13(12): 1025 - 1026.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2005 American Association for Geriatric Psychiatry